The United States Clinical Trials Market is a cornerstone of global pharmaceutical and biotechnology innovation. In 2025, the market was valued at USD 27.89 billion, reflecting the country’s leadership in biomedical research, advanced healthcare infrastructure, and strong regulatory oversight. Driven by increasing R&D investments, rising prevalence of chronic and rare diseases, and...